Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

21.33
Delayed Data
As of Jul 31
 +0.28 / +1.33%
Today’s Change
11.87
Today|||52-Week Range
23.67
+33.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues42.4M11.8M24.3M59.9M
 
 
 
 
 
Cost of Goods Sold531.0K1.8M6.1M12.2M
 
 
 
 
 
Depreciation And Amortization745.0K708.0K587.0K940.0K
 
 
 
 
 
 
Operating ExpensesGross Income41.1M9.3M17.7M46.7M
 
 
 
 
 
General Expenses24.4M20.4M20.5M45.0M
 
 
 
 
 
Other Operating Expenses1.9M0.000.000.00
 
 
Research And Development19.2M14.1M5.0M6.9M
 
 
 
 
 
Total Operating Expenses27.6M23.0M27.1M58.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.8M-11.2M-2.8M1.7M
 
 
 
 
 
Extraordinary Credit0.000.00401.0K--
 
 
Extraordinary Charge0.000.00---401.0K
 
 
Other Expenses100.0K49.0K13.0K-1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income14.9M-11.1M-2.4M-53.0K
 
 
 
 
 
Income Taxes-43.0K-37.0K-1.3M-193.0K
 
 
 
 
 
Discontinued Operations0.000.00-6.7M-1.5M
 
 
 
Extraordinary Items0.000.0049.4M0.00
 
 
Net Income14.9M-11.1M-7.8M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.8M32.9M33.3M34.3M
 
 
 
 
 
Shares To Calculate EPS Diluted33.1M32.9M33.3M34.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.45-$0.34$1.25-$0.05
 
 
 
 
 
EPS Diluted$0.45-$0.34-$0.23-$0.05